Radius Health Company Profile (NASDAQ:RDUS)

Analyst Ratings

Consensus Ratings for Radius Health (NASDAQ:RDUS) (?)
Ratings Breakdown: 2 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $68.88 (52.18% upside)

Analysts' Ratings History for Radius Health (NASDAQ:RDUS)
Show:
DateFirmActionRatingPrice TargetActions
5/31/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016HC WainwrightInitiated CoverageBuy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016Cantor FitzgeraldReiterated RatingBuy$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Jefferies GroupDowngradeBuy -> Hold$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2016Bank of America Corp.Reiterated RatingBuy$89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015Deutsche Bank AGInitiated CoverageBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Maxim GroupDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Radius Health (NASDAQ:RDUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q116($0.74)($0.94)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.64)($0.77)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.58)($0.68)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.52)($0.61)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.52)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2015Q414($0.63)($0.55)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.65)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q2($0.89)($2.22)$16.24 million$10.62 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Radius Health (NASDAQ:RDUS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.80)($0.79)($0.80)
Q2 20161($0.99)($0.99)($0.99)
Q3 20161($1.05)($1.05)($1.05)
Q4 20161($1.01)($1.01)($1.01)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Radius Health (NASDAQ:RDUS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Radius Health (NASDAQ:RDUS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/22/2016Growth N V BiotechMajor ShareholderBuy38,259$31.67$1,211,662.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2016Growth N V BiotechMajor ShareholderBuy50,000$39.90$1,995,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Gary HattersleyinsiderSell5,683$75.00$426,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Gary HattersleyinsiderSell13,333$70.00$933,310.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2015Gary HattersleyinsiderSell11,302$65.00$734,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2015Gary HattersleyinsiderSell1,501$65.36$98,105.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2015Rob WardCEOSell50,000$61.99$3,099,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Growth N. V. Biotechmajor shareholderBuy100,000$64.00$6,400,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Kurt GravesDirectorSell22,694$70.00$1,588,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Kurt GravesDirectorSell25,000$69.48$1,737,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Kurt GravesDirectorSell25,000$55.05$1,376,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015Growth N V BiotechMajor ShareholderBuy50,000$36.46$1,823,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Growth N V BiotechMajor ShareholderBuy50,000$36.23$1,811,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Growth N V BiotechMajor ShareholderBuy50,000$36.59$1,829,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Growth N V BiotechMajor ShareholderBuy50,000$38.38$1,919,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Growth N V BiotechMajor ShareholderBuy75,000$47.08$3,531,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Growth N V BiotechMajor ShareholderBuy35,000$45.74$1,600,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Morana Jovan-EmbiricosDirectorBuy587,500$8.00$4,700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Growth N V BiotechMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Radius Health (NASDAQ:RDUS)
DateHeadline
07/22/16 05:54 PMCommit To Purchase Radius Health At $22.50, Earn 8.9% Annualized Using Options
07/22/16 09:00 AMIs Radius Health Inc a Buy? The Stock Rises Again - Consumer Eagle
07/22/16 09:00 AMRadius Health, Inc. (NASDAQ:RDUS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 09:00 AMEquity Roundup: Stock Performance Focus on Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph
07/22/16 09:00 AMRadius Health Incorporated (NASDAQ:RDUS) Sellers Covered 2.52% of Their Shorts - Press Telegraph
07/20/16 03:20 PMRadius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual Meeting September 16-19, 2016 - [GlobeNewswire] - WALTHAM, Mass., July 20, 2016-- Radius Health, Inc., a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine ...
07/20/16 08:55 AMRadius Health (RDUS) Enters Manufacturing Services Agreement Lonza Sales - StreetInsider.com
07/20/16 08:55 AMShares Positive Over the Past Month: Radius Health, Inc. (NASDAQ:RDUS) - TGP
07/17/16 05:28 PMShares Moving Down on the Week: Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily
07/16/16 09:20 AMShares Experiencing a Downtrend: Radius Health, Inc. (NASDAQ:RDUS) - TGP
07/16/16 09:20 AMRadius Health Inc.: Radius Health to Announce Second Quarter 2016 Financial Results, Host Conference Call and ... - The Wall Street Transcript
07/15/16 05:04 PMTrading Performance and Target Watch for Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph
07/15/16 05:04 PMAnalyst Target and Average Rating Watch: Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph
07/15/16 05:04 PMRadius Health, Inc. (NASDAQ:RDUS) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 05:04 PMRadius Health to Announce Second Quarter 2016 Financial Results, Host Conference Call and Live Webcast on ... - GlobeNewswire (press release)
07/15/16 05:04 PMRadius Health Inc Realized Volatility Hits Elevated Level - CML News
07/15/16 10:37 AMRadius Health to Announce Second Quarter 2016 Financial Results, Host Conference Call and Live Webcast on August 4, 2016 - [GlobeNewswire] - WALTHAM, Mass., July 15, 2016-- Radius Health announced today that it will release its second quarter 2016 financial results on Thursday, August 4, 2016.. In connection with the earnings release, Radius ...
07/12/16 10:29 AMShares Moving Up Over the Past Quarter: Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily
07/09/16 05:28 PMIs $70 Within Reach For Radius Health, Inc. (NASDAQ:RDUS)? - Investor Newswire
07/08/16 08:57 AMCan Radius Health, Inc. (NASDAQ:RDUS) Improve on the Earnings Front? - Engelwood Daily
07/08/16 08:57 AMStock Highlights: Radius Health, Inc. (NASDAQ:RDUS), Sophiris Bio, Inc. (NASDAQ:SPHS), Vodafone Group Plc ... - KC Register
07/08/16 08:56 AMCompany Stock Focus for Radius Health, Inc. (NASDAQ:RDUS): Which Way Will Shares Head? - Press Telegraph
07/08/16 08:56 AMBroker Outlook For Radius Health, Inc. (RDUS) - Fiscal Standard
07/07/16 06:07 PMRadius Health, Inc. (RDUS) Updated Price Targets - FTSE News
07/05/16 05:49 PMRadius Health, Inc. (NASDAQ:RDUS) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/05/16 05:49 PMRadius Health, Inc. (RDUS) Broker Price Targets For The Coming Week - Fiscal Standard
07/05/16 10:30 AMWhy Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics
07/05/16 06:21 AMRadius Health to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference - [at noodls] - WALTHAM, Mass., July 05, 2016 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis, hormone ...
07/02/16 05:39 PMCovering the Bases on Radius Health, Inc. (NASDAQ:RDUS): Where is the Stock Going? - Press Telegraph
07/02/16 05:39 PMNew Broker Ratings For Radius Health, Inc. (RDUS) - FTSE News
07/02/16 05:39 PMRadius Health Incorporated (NASDAQ:RDUS) Shorted Shares Increased 2.37% After Market Selling - Press Telegraph
07/02/16 05:39 PMRadius Health, Inc. (NASDAQ:RDUS) Expected to Reach Highs Of $70 - Investor Newswire
06/29/16 03:01 PMRADIUS HEALTH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement -
06/28/16 05:59 PMTop Stock Pick for Quarter: Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily
06/28/16 05:59 PMRadius Health, Inc. (NASDAQ:RDUS) Company Rating and Target Watch - Telanagana Press
06/27/16 10:16 AMStock Tracing Lower on the Week Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily
06/27/16 10:16 AMShare Update and Earnings Review for Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph
06/27/16 10:16 AMNext Weeks Broker Price Targets For Radius Health, Inc. (RDUS) - Fiscal Standard
06/26/16 05:08 PMStrong Sell Calls Recommendations For Radius Health, Inc. (NASDAQ:RDUS) At 0 - Investor Newswire
06/23/16 06:43 PMEquity Research and Technical Review on Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph
06/22/16 06:01 PMBig Earnings Movers: Radius Health, Inc. (RDUS) - iStreetWire
06/22/16 06:01 PMRadius Health, Inc. (NasdaqGM:RDUS) Stock Momentum at Critical Inflection Point - CML News
06/21/16 07:45 PMRadius Health opens Philadelphia facility with plans to hire 100-plus -
06/21/16 05:36 PMBoston-area biopharm firm to add 100 jobs in Philaelphia suburbs
06/20/16 07:38 AMStrong Buy Calls Count For Radius Health, Inc. (NASDAQ:RDUS) At 5 - Investor Newswire
06/20/16 07:38 AMThis Weeks Broker Views For Radius Health, Inc. (RDUS) - Fiscal Standard
06/08/16 09:04 AMRADIUS HEALTH INC. (NASDAQ:RDUS) Financial Condition Compared to S&P 500 - CML News
06/06/16 09:46 AMConns Inc. (NASDAQ:CONN) Declined -1.39%: Radius Health, Inc. (NASDAQ:RDUS), JinkoSolar Holding Co., Ltd ... - KC Register
06/05/16 08:47 AMRadius Health's (RDUS) Buy Rating Reaffirmed at Canaccord Genuity - Let Me Know About This
06/03/16 06:42 PMWellCare Health Plans, Inc. (NYSE:WCG) Went Up 2.58%: Radius Health (NASDAQ:RDUS), Glu Mobile (NASDAQ ... - KC Register

Social

About Radius Health

Radius Health logoRadius Health, Inc. is a science-driven biopharmaceutical company focused on developing therapeutics for patients with osteoporosis, oncology and endocrine diseases. The Company's lead product candidate is the investigational drug abaloparatide for subcutaneous injection (abaloparatide-SC), which has completed Phase III development for potential use in the reduction of fracture risk in postmenopausal women with osteoporosis. Its abaloparatide-SC is under regulatory review in Europe. Its clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis, and the investigational drug RAD1901 for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its preclinical pipeline includes RAD140, which is an orally bioavailable non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under investigation for potential applications in oncology and multiple conditions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RDUS
  • CUSIP:
Key Metrics:
  • Previous Close: $45.26
  • 50 Day Moving Average: $38.08
  • 200 Day Moving Average: $35.50
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.95B
  • Beta: 1.17
  • Current Year EPS Consensus Estimate: $-4.07 EPS
  • Next Year EPS Consensus Estimate: $-3.58 EPS
Additional Links:
Radius Health (NASDAQ:RDUS) Chart for Saturday, July, 23, 2016